2014 HOPP Final Rule Expected to Have Dramatic Consequences on U.S. Wound Management Market
Vancouver, BC (PRWEB) September 24, 2014 -- According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the U.S. Wound Management Market is expected to grow to over $10 billion by 2020. Growth will be driven by the introduction of new products that will be easier to use. However, this will be hindered by changes to reimbursement, specific to the U.S. interactive dressings market. The interactive dressings market is further segmented into collagen dressings and skin substitutes.
“The skin substitutes market account for the majority of the interactive dressings market and will be significantly affected in the 2014 HOPP Final Rule, “says Dr. Kamran Zamanian, CEO of iData, “codes for many major manufacturers will expire in 2015.”
Revived interest in combination collagen dressings is expected to drive the collagen market. However, growth is expected to be hindered by the recent changes in the Pricing Data Analysis and Coding (PDAC) as well as Healthcare Common Procedure Coding System (HCPCS). This change has resulted in the removal of all collagen dressings which contain less than 90% of collagen from the collagen reimbursement codes.
Competitors leading the U.S. interactive dressings market include Organogenesis with their Apligraf®, Systagenix, Smith & Nephew, MiMedx and Osiris.
For more information
The U.S. Wound and Tissue Management Market report covers wound closure devices, static compression therapy, dynamic compression therapy, advanced dressings, hemostats, tissue sealants, anti-adhesion products and negative wound pressure therapy.
The full reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success strategies in each market and segment
Get your free synopsis of the U.S. Wound and Tissue Management Market
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.
Caroline Lau, iData Research, http://www.idataresearch.com, +1 604-266-6933 Ext: 215, [email protected]
Share this article